Patient-Reported Outcomes in Immuno-Oncology: An Educational Series

Patient-reported outcomes (PROs), or health outcomes directly reported by the patient, are a critical piece for the multidisciplinary cancer care team in assessing the health of a patient and the effect of treatments.This is particularly relevant in the emerging field of immuno-oncology (IO). In this educational webinar series, hear from experts in the field discuss the basics of PROs, how PROs can be integrated into IO clinical care, and how PROs can be used in IO clinical trials. 

Key:

Complete
Failed
Available
Locked
Patient-Reported Outcomes 101
Patient-Reported Outcomes 101: Pre-Assessment
4 Questions  |  1 attempt  |  0/4 points to pass
4 Questions  |  1 attempt  |  0/4 points to pass
Patient-Reported Outcomes 101
Open to view video.
Open to view video. In this webinar, learn the basics of PROs and what value these outcome measures hold for immuno-oncology. At the end of this webinar, learners will be able to: a) Define patient-reported outcomes and list examples. b) Describe the history of patient-reported outcomes integration in clinical trials and clinical care. c) Explain the value of patient-reported outcomes in oncology and immuno-oncology.
Patient-Reported Outcomes 101: Post-Assessment
4 Questions  |  1 attempt  |  0/4 points to pass
4 Questions  |  1 attempt  |  0/4 points to pass
PROs in Immuno-Oncology Clinical Care
PROs in Immuno-Oncology Clinical Care: Pre-Assessment
4 Questions  |  1 attempt  |  0/4 points to pass
4 Questions  |  1 attempt  |  0/4 points to pass
PROs in Immuno-Oncology Clinical Care
Open to view video.
Open to view video. In this webinar, learn about how PROs can be integrated into everyday clinical care, particularly in the management of patients receiving immunotherapies. At the end of the webinar, learners will be able to: a) Summarize the value of patient-reported outcomes in monitoring immunotherapy patients during treatment. b) Describe the challenges to integrating patient-reported outcomes into clinical practice. c) Discuss future directions for integration of patient-reported outcomes in immuno-oncology.
PROs in Immuno-Oncology Clinical Care: Post-Assessment
4 Questions  |  1 attempt  |  0/4 points to pass
4 Questions  |  1 attempt  |  0/4 points to pass
PROs and Immuno-Oncology Clinical Trials
PROs and Immuno-Oncology Clinical Trials: Pre-Assessment
4 Questions  |  1 attempt  |  0/4 points to pass
4 Questions  |  1 attempt  |  0/4 points to pass
PROs and Immuno-Oncology Clinical Trials
Open to view video.
Open to view video. In this webinar, learn about how PROs have been integrated into oncology clinical trials, how PROs are validated, and the challenges to incorporating PROs into IO clinical trials. At the end of the webinar, learners will be able to: a) Summarize how PROs have been used in oncology clinical trials. b) Describe the validation process for PRO instruments and define what it means for a PRO instrument to be “valid”. c) Identify common strategies for integrating patient-reported outcomes into clinical trials. d) Discuss FDA use of patient-reported outcomes and regulatory considerations. e) Describe current challenges to including PROs in immuno-oncology clinical trials.
PROs and Immuno-Oncology Clinical Trials: Post-Assessment
4 Questions  |  1 attempt  |  0/4 points to pass
4 Questions  |  1 attempt  |  0/4 points to pass
Evaluation
5 Questions